evidence: Factually inaccurate: The lawsuit, alleging an FDA advisory warning against taking ivermectin for COVID-19 illegally interfered with physicians’ practice of medicine, was dismissed following a settlement between the FDA and plaintiffs. The court didn’t find that the FDA broke the law. Misleading: The lawsuit has no bearing on whether ivermectin is effective against COVID-19. Well-performed clinical trials didn’t find that ivermectin produces meaningful benefits in COVID-19 patients. Ivermectin remains unapproved and unauthorized by the FDA for treating COVID-19. [...] Claims that a court found the FDA broke the law with its ivermectin advisory or that it lost the case are inaccurate and misrepresent the outcome of the case. Furthermore, the outcome also has no bearing on whether ivermectin is effective for COVID-19. Multiple clinical trials have detected no meaningful benefit from treating COVID-19 with ivermectin.